N/A
Completed N=743
Treatment Preference and Patient Centered Prostate Cancer Care
Source: ClinicalTrials.gov NCT02032550 ↗Enrolled (actual)
743
Serious AEs
0.0%
Results posted
Aug 2020
Primary outcomePrimary: Change in Satisfaction With Care — 0.26; 0.07; 0.28; 0.06 units on a scale
Summary
The purpose of this study is to develop a preference based decision aid to assess the treatment preferences of prostate cancer patients, and to analyze the interaction of treatment preferences, type of treatment received and their relationship with health related quality of life, satisfaction with care, decision regret, and psychological health of men with localized prostate cancer.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Satisfaction With Care |
0.26; 0.07; 0.28; 0.06; 0.31; 0.15 | — |
| SECONDARY Generic Health Related Quality of Life (HRQoL) |
-0.13; -2.9 | — |
| SECONDARY Anxiety |
— | — |
| SECONDARY Urinary Symptoms |
— | — |
| SECONDARY Treatment Choice |
— | — |
| SECONDARY Depression |
— | — |
| SECONDARY Satisfaction With Decision |
— | — |
| SECONDARY Prostate Specific Health Related Quality of Life (HRQoL) |
59.4; 50 | — |
Eligibility Criteria
Inclusion Criteria
- Newly diagnosed with non-metastatic prostate cancer
- Has not yet started radiation or surgery
- Provide informed consent
Exclusion Criteria
- Distant, metastatic prostate cancer at diagnosis
- Has already begun treatment for prostate cancer
- Unable to communicate in English
Data sourced from ClinicalTrials.gov (NCT02032550). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.